UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 63

Sortiert nach

CD52‐negative T cells predict acute graft‐versus‐host disease after an alemtuzumab‐based conditioning regimen

British journal of haematology, 2020-10, Vol.191 (2), p.253-262

2020

Volltextzugriff (PDF)

Treosulfan compared with reduced‐intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial

American journal of hematology, 2022-08, Vol.97 (8), p.1023-1034

2022

Volltextzugriff (PDF)

Additional cytogenetic features determine outcome in patients allografted for TP53 mutant acute myeloid leukemia

Cancer, 2022-08, Vol.128 (15), p.2922-2931

2022

Volltextzugriff (PDF)

An investigation of the diagnostic, predictive, and prognostic impacts of three colonic biopsy grading systems for acute graft versus host disease

PloS one, 2021-08, Vol.16 (8), p.e0256543-e0256543

2021

Volltextzugriff (PDF)

Fertilitätsprotektive Versorgung hämatoonkologischer Patientinnen im Rhein-Main-Gebiet

Geburtshilfe und Frauenheilkunde, 2023-07, Vol.83 (7), p.790-795

2023

Volltextzugriff (PDF)

Allogeneic stem cell transplantation for acquired pure red cell aplasia

American journal of hematology, 2019-11, Vol.94 (11), p.E294-E296

2019

Volltextzugriff (PDF)

GLA/DRST real-world outcome analysis of CAR-T cell therapies for large B-cell lymphoma in Germany

Blood, 2022-07, Vol.140 (4), p.349-358

2022

Volltextzugriff (PDF)

P1387: TREATMENT WITH A LEUKEMIA‐DERIVED DENDRITIC CELL VACCINE INDUCES INNATE AND ADAPTIVE IMMUNE RESPONSE CORRELATING WITH CLINICAL RESPONSE IN AML PATIENTS IN CR1 WITH MEASURABLE RESIDUAL DISEASE

HemaSphere, 2023-08, Vol.7 (S3), p.e95344a6-n/a

2023

Volltextzugriff (PDF)

Diagnosis of sinusoidal obstruction syndrome: can biopsy be the key?

Annals of hematology, 2023-12, Vol.102 (12), p.3635-3637

2023

Volltextzugriff (PDF)

Comparative analysis of CAR T-cell therapy access for DLBCL patients: associated challenges and solutions in the four largest EU countries

Frontiers in medicine, 2023, Vol.10, p.1128295-1128295

2023

Volltextzugriff (PDF)

Prognostic factors and outcome of adult allogeneic hematopoietic stem cell transplantation patients admitted to intensive care unit during transplant hospitalization

Scientific reports, 2019-12, Vol.9 (1), p.19911-7, Article 19911

2019

Volltextzugriff (PDF)

Treatment of newly diagnosed moderate or severe chronic graft-versus-host disease with prednisone and everolimus (PredEver first): a prospective multicenter phase IIA study

Bone marrow transplantation (Basingstoke), 2024-05, Vol.59 (8), p.1092-1096

2024

Volltextzugriff (PDF)

Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients - A clinical trial to registry data comparison

Bone marrow transplantation (Basingstoke), 2024-05, Vol.59 (5), p.670-679

2024

Volltextzugriff (PDF)

A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy

Leukemia, 2021-06, Vol.35 (6), p.1763-1772

2021

Volltextzugriff (PDF)

Veno-occlusive disease of the lung after allogeneic haematopoietic stem-cell transplantation: An autopsy study

Pathology, research and practice, 2022-03, Vol.231, p.153799-153799, Article 153799

2022

Volltextzugriff (PDF)

HLA-DRB3/4/5 Matching Improves Outcome of Unrelated Hematopoietic Stem Cell Transplantation

Frontiers in immunology, 2021-12, Vol.12, p.771449-771449

2021

Volltextzugriff (PDF)

Dermatopathic lymphadenopathy with Langerhans cell chimerism in graft‐versus‐host disease of the skin

European journal of haematology, 2017-12, Vol.99 (6), p.582-585

2017

Volltextzugriff (PDF)

The Human Leukocyte Antigen-DPB1 Degree of Compatibility Is Determined by Its Expression Level and Mismatch Permissiveness: A German Multicenter Analysis

Frontiers in immunology, 2021-01, Vol.11, p.614976-614976

2021

Volltextzugriff (PDF)

Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial

The Lancet. Haematology, 2024-05, Vol.11 (5), p.e324-e335

2024

Volltextzugriff (PDF)

LBP1 Interim results of an open-label, multicentre, Phase 1/2 study to assess YTB323 (rapcabtagene autoleucel), a CAR T-cell therapy, for severe refractory systemic lupus erythematosus

Lupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A170-A171

2024

Volltextzugriff (PDF)

1 – 25 von 63

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(62)

Publikationsform

Artikel
(62)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(38)
Life Sciences & Biomedicine
(36)
Hematology
(28)
Humans
(23)
Transplantation
(21)
Oncology
(18)
Stem Cell Transplantation
(18)
Immunology
(17)
Adult
(14)
Middle Aged
(13)
Female
(12)
Hematopoietic Stem Cell Transplantation
(12)
Hematopoietic Stem Cells
(12)
Male
(12)
Aged
(11)
Stem Cells
(11)
Biophysics
(9)
Patients
(9)
Retrospective Studies
(9)
Allografts
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

CD52‐negative T cells predict acute graft‐versus‐host disease after an alemtuzumab‐based conditioning regimen

Treosulfan compared with reduced‐intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial

Additional cytogenetic features determine outcome in patients allografted for TP53 mutant acute myeloid leukemia

An investigation of the diagnostic, predictive, and prognostic impacts of three colonic biopsy grading systems for acute graft versus host disease

Fertilitätsprotektive Versorgung hämatoonkologischer Patientinnen im Rhein-Main-Gebiet

Allogeneic stem cell transplantation for acquired pure red cell aplasia

GLA/DRST real-world outcome analysis of CAR-T cell therapies for large B-cell lymphoma in Germany

P1387: TREATMENT WITH A LEUKEMIA‐DERIVED DENDRITIC CELL VACCINE INDUCES INNATE AND ADAPTIVE IMMUNE RESPONSE CORRELATING WITH CLINICAL RESPONSE IN AML PATIENTS IN CR1 WITH MEASURABLE RESIDUAL DISEASE

P352: PROPHYLACTIC AND PREEMPTIVE USE OF DLI COMPARE FAVOURABLY TO THEIR THERAPEUTIC USE IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) – RESULTS OF A MULTICENTRE RETROSPECTIVE STUDY

Diagnosis of sinusoidal obstruction syndrome: can biopsy be the key?

Comparative analysis of CAR T-cell therapy access for DLBCL patients: associated challenges and solutions in the four largest EU countries

S225: ALLOGENEIC STEM CELL TRANSPLANTATION FOR NK/T‐CELL LYMPHOMA IN THE ERA OF ASPARAGINASE‐BASED CHEMOTHERAPY: A RETROSPECTIVE ANALYSIS OF THE EBMT LYMPHOMA WORKING PARTY

Prognostic factors and outcome of adult allogeneic hematopoietic stem cell transplantation patients admitted to intensive care unit during transplant hospitalization

Treatment of newly diagnosed moderate or severe chronic graft-versus-host disease with prednisone and everolimus (PredEver first): a prospective multicenter phase IIA study

Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients - A clinical trial to registry data comparison

Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group

The impact of MICB mismatches in unrelated haematopoietic stem cell transplantation

Higher risk for chronic graft‐versus‐host disease (GvHD) in HLA‐G mismatched transplants following allogeneic hematopoietic stem cell transplantation: A retrospective study

A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy

Veno-occlusive disease of the lung after allogeneic haematopoietic stem-cell transplantation: An autopsy study

HLA-DRB3/4/5 Matching Improves Outcome of Unrelated Hematopoietic Stem Cell Transplantation

Dermatopathic lymphadenopathy with Langerhans cell chimerism in graft‐versus‐host disease of the skin

The Human Leukocyte Antigen-DPB1 Degree of Compatibility Is Determined by Its Expression Level and Mismatch Permissiveness: A German Multicenter Analysis

Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial

LBP1 Interim results of an open-label, multicentre, Phase 1/2 study to assess YTB323 (rapcabtagene autoleucel), a CAR T-cell therapy, for severe refractory systemic lupus erythematosus

Suchergebnisse filtern